161 related articles for article (PubMed ID: 36210541)
1. A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen.
Karaushi H; Seki M; Miyawaki Y; Watanabe N; Kamoshita F; Mitsutake K
Am J Case Rep; 2022 Oct; 23():e937485. PubMed ID: 36210541
[TBL] [Abstract][Full Text] [Related]
2. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
3. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis in neonates and infants: epidemiology, pathogenesis, clinical manifestations, diagnosis, and management issues.
Skevaki CL; Kafetzis DA
Paediatr Drugs; 2005; 7(4):219-34. PubMed ID: 16117559
[TBL] [Abstract][Full Text] [Related]
5. [Epidural abscess due to a Mycobacterium tuberculosis strain with primary resistance to isoniazid and ethambutol].
Sener A; Akçalı A; Karatağ O; Koşar S; Değirmenci Y; Akman T
Mikrobiyol Bul; 2012 Oct; 46(4):689-94. PubMed ID: 23188583
[TBL] [Abstract][Full Text] [Related]
6. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
Mesfin EA; Merker M; Beyene D; Tesfaye A; Shuaib YA; Addise D; Tessema B; Niemann S
PLoS One; 2022; 17(8):e0271508. PubMed ID: 35930613
[TBL] [Abstract][Full Text] [Related]
7. A case of isoniazid-resistant miliary tuberculosis in which tuberculous meningitis paradoxically developed despite systemic improvement.
Ikegame S; Wakamatsu K; Fujita M; Nakanishi Y; Harada M; Kajiki A
J Infect Chemother; 2011 Oct; 17(5):689-93. PubMed ID: 21327690
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
Wada M
Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
[TBL] [Abstract][Full Text] [Related]
9. Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo.
Zhao W; Zheng M; Wang B; Mu X; Li P; Fu L; Liu S; Guo Z
Int J Infect Dis; 2016 Nov; 52():23-28. PubMed ID: 27613365
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
Dickinson JM; Aber VR; Mitchison DA
Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480.
Alffenaar JW; van der Laan T; Simons S; van der Werf TS; van de Kasteele PJ; de Neeling H; van Soolingen D
Antimicrob Agents Chemother; 2011 Mar; 55(3):1287-9. PubMed ID: 21199931
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium abscessus Associated Peritonitis with CAPD Successfully Treated Using a Linezolid and Tedizolid Containing Regimen Suggested Immunomodulatory Effects.
Seki M; Kamioka Y; Takano K; Imai H; Shoji M; Hariu M; Kabutoya Y; Watanabe Y
Am J Case Rep; 2020 Jun; 21():e924642. PubMed ID: 32598338
[TBL] [Abstract][Full Text] [Related]
13. Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant.
Ishiwada N; Tokunaga O; Nagasawa K; Ichimoto K; Kinoshita K; Hishiki H; Kohno Y
Tohoku J Exp Med; 2013 Mar; 229(3):221-5. PubMed ID: 23470647
[TBL] [Abstract][Full Text] [Related]
14. [A case of multidrug-resistant tuberculosis who acquired additional resistance to ethambutol before the result of the initial drug sensitivity test was reported].
Wakabayashi K; Yano S; Kobayashi K; Kadowaki T; Kimura M; Ishikawa S; Ikeda T
Kekkaku; 2010 Aug; 85(8):679-82. PubMed ID: 20845688
[TBL] [Abstract][Full Text] [Related]
15. Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009.
Gegia M; Cohen T; Kalandadze I; Vashakidze L; Furin J
Int J Tuberc Lung Dis; 2012 Jun; 16(6):812-6. PubMed ID: 22507372
[TBL] [Abstract][Full Text] [Related]
16. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
[TBL] [Abstract][Full Text] [Related]
17. Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis.
Fregonese F; Ahuja SD; Akkerman OW; Arakaki-Sanchez D; Ayakaka I; Baghaei P; Bang D; Bastos M; Benedetti A; Bonnet M; Cattamanchi A; Cegielski P; Chien JY; Cox H; Dedicoat M; Erkens C; Escalante P; Falzon D; Garcia-Prats AJ; Gegia M; Gillespie SH; Glynn JR; Goldberg S; Griffith D; Jacobson KR; Johnston JC; Jones-López EC; Khan A; Koh WJ; Kritski A; Lan ZY; Lee JH; Li PZ; Maciel EL; Galliez RM; Merle CSC; Munang M; Narendran G; Nguyen VN; Nunn A; Ohkado A; Park JS; Phillips PPJ; Ponnuraja C; Reves R; Romanowski K; Seung K; Schaaf HS; Skrahina A; Soolingen DV; Tabarsi P; Trajman A; Trieu L; Banurekha VV; Viiklepp P; Wang JY; Yoshiyama T; Menzies D
Lancet Respir Med; 2018 Apr; 6(4):265-275. PubMed ID: 29595509
[TBL] [Abstract][Full Text] [Related]
18. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
Monaldi Arch Chest Dis; 1994 Sep; 49(4):327-45. PubMed ID: 8000420
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of tedizolid and linezolid against multidrug-resistant Mycobacterium tuberculosis: a comparative study using microdilution broth assay and genomics.
Aono A; Murase Y; Chikamatsu K; Igarashi Y; Shimomura Y; Hosoya M; Osugi A; Morishige Y; Takaki A; Yamada H; Mitarai S
Diagn Microbiol Infect Dis; 2022 Jul; 103(3):115714. PubMed ID: 35596983
[TBL] [Abstract][Full Text] [Related]
20. Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.
Diacon AH; De Jager VR; Dawson R; Narunsky K; Vanker N; Burger DA; Everitt D; Pappas F; Nedelman J; Mendel CM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
